Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280497425> ?p ?o ?g. }
- W4280497425 endingPage "2878" @default.
- W4280497425 startingPage "2863" @default.
- W4280497425 abstract "To present the current evidence and the development of studies in recent years on the management of extragonadal germ cell tumors (EGCT).A systematic literature search was conducted in Medline and the Cochrane Library. Studies within the search period (January 2010 to February 2021) that addressed the classification, diagnosis, prognosis, treatment, and follow-up of extragonadal tumors were included. Risk of bias was assessed and relevant data were extracted in evidence tables.The systematic search identified nine studies. Germ cell tumors (GCT) arise predominantly from within the testis, but about 5% of the tumors are primarily located extragonadal. EGCT are localized primarily mediastinal or retroperitoneal in the midline of the body. EGCT patients are classified according to the IGCCCG classification. Consecutively, all mediastinal non-seminomatous EGCT patients belong to the poor prognosis group. In contrast mediastinal seminoma and both retroperitoneal seminoma and non-seminoma patients seem to have a similar prognosis as patients with gonadal GCTs and metastasis at theses respective sites. The standard chemotherapy regimen for patients with a EGCT consists of 3-4 cycles (good vs intermediate prognosis) of bleomycin, etoposid, cisplatin (BEP); however, due to their very poor prognosis patients with non-seminomatous mediastinal GCT should receive a dose-intensified or high-dose chemotherapy approach upfront on an individual basis and should thus be referred to expert centers Ifosfamide may be exchanged for bleomycin in cases of additional pulmonary metastasis due to subsequently planned resections. In general patients with non-seminomatous EGCT, residual tumor resection (RTR) should be performed after chemotherapy.In general, non-seminomatous EGCT have a poorer prognosis compared to testicular GCT, while seminomatous EGGCT seem to have a similar prognosis to patients with metastatic testicular seminoma. The current insights on EGCT are limited, since all data are mainly based on case series and studies with small patient numbers and non-comparative studies. In general, systemic treatment should be performed like in testicular metastatic GCTs but upfront dose intensification of chemotherapy should be considered for mediastinal non-seminoma patients. Thus, EGCT should be referred to interdisciplinary centers with utmost experience in the treatment of germ cell tumors." @default.
- W4280497425 created "2022-05-22" @default.
- W4280497425 creator A5001453186 @default.
- W4280497425 creator A5010990966 @default.
- W4280497425 creator A5011305627 @default.
- W4280497425 creator A5013173067 @default.
- W4280497425 creator A5015188002 @default.
- W4280497425 creator A5023936550 @default.
- W4280497425 creator A5053148625 @default.
- W4280497425 creator A5055275116 @default.
- W4280497425 creator A5068364488 @default.
- W4280497425 creator A5078383767 @default.
- W4280497425 creator A5087317766 @default.
- W4280497425 date "2022-05-12" @default.
- W4280497425 modified "2023-09-30" @default.
- W4280497425 title "How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence" @default.
- W4280497425 cites W1462373416 @default.
- W4280497425 cites W1852554427 @default.
- W4280497425 cites W1897230212 @default.
- W4280497425 cites W1956474138 @default.
- W4280497425 cites W1975370453 @default.
- W4280497425 cites W1980846178 @default.
- W4280497425 cites W1990616829 @default.
- W4280497425 cites W1997758116 @default.
- W4280497425 cites W2000555410 @default.
- W4280497425 cites W2003995015 @default.
- W4280497425 cites W2006246482 @default.
- W4280497425 cites W2011351862 @default.
- W4280497425 cites W2012218081 @default.
- W4280497425 cites W2016412840 @default.
- W4280497425 cites W2022136903 @default.
- W4280497425 cites W2036729799 @default.
- W4280497425 cites W2052500583 @default.
- W4280497425 cites W2058283120 @default.
- W4280497425 cites W2061295542 @default.
- W4280497425 cites W2062309393 @default.
- W4280497425 cites W2082977560 @default.
- W4280497425 cites W2084032502 @default.
- W4280497425 cites W2089852251 @default.
- W4280497425 cites W2096581811 @default.
- W4280497425 cites W2111422364 @default.
- W4280497425 cites W2112489360 @default.
- W4280497425 cites W2120820910 @default.
- W4280497425 cites W2127405017 @default.
- W4280497425 cites W2134751734 @default.
- W4280497425 cites W2136532528 @default.
- W4280497425 cites W2139000771 @default.
- W4280497425 cites W2150862148 @default.
- W4280497425 cites W2154391148 @default.
- W4280497425 cites W2154538707 @default.
- W4280497425 cites W2156098321 @default.
- W4280497425 cites W2164772224 @default.
- W4280497425 cites W2221286031 @default.
- W4280497425 cites W2226513478 @default.
- W4280497425 cites W2276440434 @default.
- W4280497425 cites W246286872 @default.
- W4280497425 cites W2522030015 @default.
- W4280497425 cites W2533936427 @default.
- W4280497425 cites W2611162286 @default.
- W4280497425 cites W3119115985 @default.
- W4280497425 cites W3124678683 @default.
- W4280497425 cites W3150204614 @default.
- W4280497425 cites W4294215472 @default.
- W4280497425 cites W4296588056 @default.
- W4280497425 cites W4297811456 @default.
- W4280497425 cites W44254208 @default.
- W4280497425 doi "https://doi.org/10.1007/s00345-022-04009-z" @default.
- W4280497425 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35554637" @default.
- W4280497425 hasPublicationYear "2022" @default.
- W4280497425 type Work @default.
- W4280497425 citedByCount "3" @default.
- W4280497425 countsByYear W42804974252023 @default.
- W4280497425 crossrefType "journal-article" @default.
- W4280497425 hasAuthorship W4280497425A5001453186 @default.
- W4280497425 hasAuthorship W4280497425A5010990966 @default.
- W4280497425 hasAuthorship W4280497425A5011305627 @default.
- W4280497425 hasAuthorship W4280497425A5013173067 @default.
- W4280497425 hasAuthorship W4280497425A5015188002 @default.
- W4280497425 hasAuthorship W4280497425A5023936550 @default.
- W4280497425 hasAuthorship W4280497425A5053148625 @default.
- W4280497425 hasAuthorship W4280497425A5055275116 @default.
- W4280497425 hasAuthorship W4280497425A5068364488 @default.
- W4280497425 hasAuthorship W4280497425A5078383767 @default.
- W4280497425 hasAuthorship W4280497425A5087317766 @default.
- W4280497425 hasBestOaLocation W42804974251 @default.
- W4280497425 hasConcept C104317684 @default.
- W4280497425 hasConcept C121608353 @default.
- W4280497425 hasConcept C126322002 @default.
- W4280497425 hasConcept C126838900 @default.
- W4280497425 hasConcept C143998085 @default.
- W4280497425 hasConcept C185592680 @default.
- W4280497425 hasConcept C2776232574 @default.
- W4280497425 hasConcept C2776478404 @default.
- W4280497425 hasConcept C2776694085 @default.
- W4280497425 hasConcept C2776938808 @default.
- W4280497425 hasConcept C2777506904 @default.
- W4280497425 hasConcept C2778074268 @default.
- W4280497425 hasConcept C2778239845 @default.